收费全文 | 1754篇 |
免费 | 121篇 |
国内免费 | 2篇 |
耳鼻咽喉 | 7篇 |
儿科学 | 43篇 |
妇产科学 | 50篇 |
基础医学 | 324篇 |
口腔科学 | 28篇 |
临床医学 | 200篇 |
内科学 | 326篇 |
皮肤病学 | 21篇 |
神经病学 | 174篇 |
特种医学 | 46篇 |
外科学 | 153篇 |
综合类 | 17篇 |
一般理论 | 1篇 |
预防医学 | 173篇 |
眼科学 | 39篇 |
药学 | 116篇 |
肿瘤学 | 159篇 |
2023年 | 15篇 |
2022年 | 33篇 |
2021年 | 56篇 |
2020年 | 40篇 |
2019年 | 36篇 |
2018年 | 49篇 |
2017年 | 34篇 |
2016年 | 43篇 |
2015年 | 67篇 |
2014年 | 70篇 |
2013年 | 80篇 |
2012年 | 124篇 |
2011年 | 137篇 |
2010年 | 78篇 |
2009年 | 83篇 |
2008年 | 108篇 |
2007年 | 109篇 |
2006年 | 100篇 |
2005年 | 96篇 |
2004年 | 99篇 |
2003年 | 95篇 |
2002年 | 63篇 |
2001年 | 10篇 |
2000年 | 4篇 |
1999年 | 13篇 |
1998年 | 19篇 |
1997年 | 11篇 |
1996年 | 13篇 |
1995年 | 19篇 |
1994年 | 7篇 |
1993年 | 11篇 |
1992年 | 8篇 |
1991年 | 5篇 |
1989年 | 9篇 |
1987年 | 10篇 |
1986年 | 6篇 |
1985年 | 4篇 |
1984年 | 10篇 |
1981年 | 4篇 |
1980年 | 4篇 |
1979年 | 4篇 |
1977年 | 5篇 |
1971年 | 4篇 |
1969年 | 4篇 |
1964年 | 4篇 |
1963年 | 4篇 |
1961年 | 7篇 |
1955年 | 3篇 |
1932年 | 3篇 |
1927年 | 3篇 |
Background
A considerable number of patients develop sinusoidal obstruction syndrome (SOS) after oxaliplatin-based chemotherapy for colorectal liver metastases (CLMs). SOS is associated with adverse outcomes after major hepatectomy. Hyaluronic acid (HA) is a marker of hepatic sinusoidal endothelial cell function and may serve as an accurate marker of SOS. This study aimed to assess the value of systemic HA levels and fractional extraction (FE) of HA by the splanchnic area and liver as markers of SOS after oxaliplatin-based chemotherapy for CLMs.Methods
Forty patients were studied. The presence of SOS was assessed histopathologically. Blood samples from the radial artery and portal and hepatic veins were collected. HA levels were determined by ELISA and the FE of HA was estimated.Results
SOS was present in 23 patients, 11 of whom demonstrated moderate or severe SOS. Preoperative HA levels were significantly higher in patients with moderate or severe SOS (group B, n = 11) compared to patients with no or mild SOS (group A, n = 29) (51.6 ± 10.2 ng/mL vs. 32.1 ± 3.5 ng/mL, p = 0.030). A cutoff HA level of 44.1 ng/mL yielded a sensitivity of 67 % and specificity of 83 % for detection of SOS. The positive predictive value was 50 % and the negative predictive value 91 %. Both groups exhibited a similar FE of HA by the splanchnic area (?7.9 ± 8.5 % in Group A vs. 7.3 ± 3.6 % in Group B, p = 0.422) and liver (?10.7 ± 6.2 % in Group A vs. 4.6 ± 2.3 % in Group B, p = 0.265).Conclusions
Systemic HA levels can be used to detect patients at risk of SOS after oxaliplatin-based chemotherapy for CLMs. Additional investigations into the presence of SOS are indicated in patients with elevated HA levels. 相似文献Peer recovery specialists are an important resource in community mental health settings. This study, which was part of a larger statewide assessment, evaluates how the role impacts work and personal lives of peers, with implications for improving the training and supervision of this service. The importance of peer work has been investigated through client outcomes, however less work has investigated outcomes on peers themselves, which impacts the work force and service delivery. Nine focus groups were conducted with peer recovery specialists. A two-stage qualitative analysis led to two overarching themes, work and personal, and six subthemes. Findings suggest being a peer presents unique benefits and challenges in work and personal life. Peers benefit from more training and supervision, consistency within the role, and maintaining boundaries. Additionally, work environment roles may be improved by attention to needs of supervisors in terms of skills for effective supervision and clarification of supervisory roles.
相似文献Methods: The tool was developed by a panel of pharmacovigilance experts. It includes four domains: ADR, chronology of the ADR, suspected drug and patient characteristics. The final score categorizes reports into: excellent, well, moderately or poorly documented.
In two rounds, eight pharmacovigilance assessors of different countries made a total of 224 assessments using the tool, with the expert panels judgement as a standard. Sensitivity and specificity were calculated.
Results: The tool with four outcome-categories demonstrated low sensitivity. A lack of distinctiveness was demonstrated between the categories moderate and well. Results for the second round were re-analysed using three categories. This demonstrated a better validity.
Conclusion: This is the first tool to give insight in the level of relevant clinical information present in ADR reports. It can be used internationally to compare reports coming from different reporting methods and different types of reporters in pharmacovigilance. 相似文献